Clinical Trial: Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132880

Registration Time: 2026/09/19

Type: Diagnostic test

Primary Sponsor: Zhongshan People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344083

Published by HT Digital Content Services with permission from Health Daily Digest....